Abeona Therapeutics Inc. is a commercial-stage biopharmaceutical company focused on developing cell and gene therapies for serious diseases. The company operates a cGMP manufacturing facility in Cleveland, Ohio, which produces its approved therapy ZEVASKYN® (prademagene zamikeracel). Abeona's development pipeline includes PSMA-SIR-T™, an engineered T-cell therapy targeting Prostate-Specific Membrane Antigen (PSMA) for treating solid tumors.
